Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

C21 Investments Inc. CXXIF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
33/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

C21 Investments Inc. (CXXIF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.27. It has a SharesGrow Score of 31/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $33M, +5.1%/yr average growth. Net income is $3M (loss), growing at -411.3%/yr. Net profit margin is -10.3% (negative). Gross margin is 39.2% (-7.2 pp trend).

Balance sheet: total debt is $11M against $27M equity (Debt-to-Equity (D/E) ratio 0.41, conservative). Current ratio is 1.32 (adequate). Debt-to-assets is 19.9%. Total assets: $55M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 40/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 21/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

CXXIF SharesGrow Score Overview

33/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 21/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CXXIF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
40/100
CXXIF: +5.1%/yr revenue is, -411.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
CXXIF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet CXXIF: Debt-to-Equity (D/E) ratio 0.41 (conservative), Current ratio is 1.32 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
21/100
CXXIF: Gross margin is 39.2% (-7.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
CXXIF: Net profit margin is -10.3%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.123-0.537
Volume66.27K
Avg Volume (30D)153.29K
Market Cap$31.79M
Beta (1Y)1.84
Share Statistics
EPS (TTM)-0.03
Shares Outstanding$117.94M
IPO Date2018-06-22
Employees114
CEOSonny Newman
Financial Highlights & Ratios
Revenue (TTM)$33.4M
Gross Profit$13.11M
EBITDA$4.56M
Net Income$-3.44M
Operating Income$2.62M
Total Cash$2.42M
Total Debt$10.95M
Net Debt$8.53M
Total Assets$54.89M
Price / Earnings (P/E)-9.3
Price / Sales (P/S)0.95
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA12675Q1019

Price Chart

Track all markets on TradingView
CXXIF
C21 Investments Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.12 52WK RANGE 0.54

People Also View

GRUSF
GRUSF
Grown Rogue International Inc.
$0.32
+3.90%
 SSIC
SSIC
Silver Spike Investment Corp.
$10.74
+1.27%
 GDNSF
GDNSF
Goodness Growth Holdings, Inc.
$0.45
+0.00%
 DBCCF
DBCCF
Decibel Cannabis Company Inc.
$0.09
+3.52%
 CANSF
CANSF
Willow Biosciences Inc.
$0.11
-10.83%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 AVCNF
AVCNF
Avicanna Inc.
$0.11
-2.06%
 CLSH
CLSH
CLS Holdings USA, Inc.
$0.04
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message